Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes

American Journal of Kidney Diseases

Volumn 34, Issue 2, 1999, Pages 222-227

  Amin, N B ^a   Padhi, I D ^a   Touchette, M A ^a   Patel, R V ^a   Dunfee, T P ^a   Anandan, J V ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

End stage renal disease; Gentamicin; High flux hemodialysis membrane; Rebound phenomenon

Indexed keywords

GENTAMICIN; POLYSULFONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INDICATION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; TREATMENT FAILURE;

EID: 0032811594     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70347-1     Document Type: Article

References (11)

1. DR Goetz S Pancorbo S Hoag P Bloom Prediction of serum gentamicin concentrations in patients undergoing hemodialysis Am J Hosp Pharm 37 1980 1077 1083
2. GR Matzke CE Halstenson WF Keane Hemodialysis elimination rates and clearance of gentamicin and tobramycin Antimicrob Agents Chemother 25 1984 128 130
3. R Agarwal RD Toto Gentamicin clearance during hemodialysis: A comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers Am J Kidney Dis 22 1993 296 299
4. R Agarwal RE Cronin Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers Am J Kidney Dis 23 1994 47 51
5. GR Matzke Pharmacotherapeutic consequences of recent advances in hemodialysis therapy Ann Pharmacother 28 1994 512 514
6. MA Touchette RV Patel JV Anandan F Dumler BJ Zarowitz Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease Am J Kidney Dis 26 1995 469 474
7. LA Bauer Rebound gentamicin levels after hemodialysis Ther Drug Monit 4 1982 99 101
8. MM Catolico S Campbell WN Jones JL Logan Time course of gentamicin serum concentration rebound following hemodialysis Drug Intell Clin Pharm 21 1987 46 49
9. JJ Schentag WJ Jusko ME Plaut TJ Cumbo JW Vance E Abrutyn Tissue persistence of gentamicin in man JAMA 238 1977 327 329
10. JJ Schentag G Lasezkay ME Plaut WJ Jusko TJ Cumbo Comparative tissue accumulation of gentamicin and tobramycin in patients J Antimicrob Chemother 4 1978 23 30
11. MB Mayersohn Special pharmacokinetic considerations in the elderly WE Evans JJ Schentag WJ Jusko Applied Pharmacokinetics 1992 Applied Therapeutics Vancouver, WA 12 28